Parkinson's Disease Flashcards

1
Q

PD average age of onset

A

62

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

PD possible causes

A

mutations in alpha-synuclein gene
inverse relationship with cig smoking and caffeine consumption
DA deficiency
TWO MAIN CAUSES: loss of dopaminergic cells in substantia nigra and basal ganglia; formation of lewy bodies in remaining SN neurons and other parts of the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PD patho

A

inc DA breakdown via MAO-B –> inc hydrogen peroxide + iron ions in substantia nigra –> inc free radicals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

PD Dx

A

bradykinesia (slowness and difficulty initiating voluntary movement) and at least 1 of the following
1. limb muscle rigidity
2. resting tremor
3. postural instability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

bradykinesia

A

slowness and difficulty with motor acts
mycografia
cardinal sx
freezing can occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

PD motor sx

A

dec dexterity
dysarithria
freezing of initiating movement
slow turning

bladder and anal sphincter disturbances
constipation
diaphoresis

confusion
dementia
psychosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

on vs off

A

on = good movement (sx of tremor, rigidity, slowness are well controlled by medication)
off = poor movement (return of tremor, rigidity or slowness or complete immobility)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

DA normally _________ ACh in the striatum
why is this an issue in PD?

A

inhibits
in PD there is decreased DA so there is less inhibition of ACh –> leads to increased cholinergic activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

anticholinergic options in PD

A

benztropine
trihexyphenidyl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

carbidopa/levodopa/entacapone MOA

A

levodopa is DA metabolite
carbidopa inhibits peripheral metab by dopa decarboxylase
entacapone is a COMT-i

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

levodopa AE

A

dyskinesia
on-off, dec effectiveness w time
psychiatric disturbances, vivid dreams
nausea
orthostatic hypotension
saliva, sweat, urine discoloration
NMS w abrupt D/C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

levodopa DDI

A

DA-antagonists (metoclopramide, APs)
non-selective MAOis
high protein intake (pyridoxine)
iron salts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

levodopa dosing starting and max

A

200-300mg/d in divided doses to start
titrate up by no more than 100mg/week
MDD: 800-1000mg/d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

carbidopa/levodopa ratio availabilities

A

1:10 OR 1:4

10mg/100mg
25mg/100mg
25mg/250mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Sinemet CR
onset
IR –> CR ?

A

peak at 2 hours, can supplement with IR in am until onset
can also take at bedtime

IR –> dec freq 50% –> CR

ex) if taking IR QID change to CR BID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what dose does carbidopa need to be at when used in combination with levodopa

A

at least 70-100mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Inbrija
use
AE
CI

A

levodopa powder inhaler for intermittent tx of episodes
not to replace Sinemet
AE: cough (60%)
CI: MAOi non-sel, asthma, COPD etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

COMT-is, MOA, caveat

A

entacapone, tolcapone
inhibit L-dopa breakdown which increases its AUC by 35% and inc “on: by 1-2 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

entacapone dosing
AE
DDI

A

200mg w each dose of Sinemet p to 8x a day
AE: brown/orange urine
DDI: drugs metab by COMT, MAOi (ns)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is Stalero

A

Carbidopa/levodopa/entacapone
1:4:200 mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

why is tolcapone not used anymore

A

high risk of hepatocellular injury

22
Q

MAOi-s
MOA

A

selegiline, rasagiline
inhibit MAO-B to dec DA breakdown, sx control, dec free radical production

23
Q

rasagline pearl

A

ay be disease modifying!!!

24
Q

selegiline pearl

A

metabolites includes amphetamines which linger for WEEKS

25
selegiline CI SE DI (rasagiline too)
CI (no absolute): dementia, severe psychosis, concominant use of meperidine, tramadol, methadone, propoxyphene SE: GI, CNS, HTN crisis, serotonin syndrome, INSOMNIA, JITTERINESS, HA, irritation of buccal mucosa DI: MAOIs (ns), TCAs, SSRIs, DXM, tyramine foods, sympathomimetics
26
how long is the washout period for MAOIs
2 week washout
27
Safinamida (Xadago) MOA use dose
selective MAOB-i; Na and K channel blocker, dec glutamate release use in the wearing off sx 50 and 100mg tabs available (hepatic impairment do not exceed 50mg)
28
DA ags options and whether they are ergot or non ergot
pramipexole, ropinorole, rotigotine (Neupro) - non ergot bromocriptine, cabergoline, pergoline - ergot
29
pramipexole dosing DDI
renal dosing for <60mL/min *start low, go slow* IR: 1.25mg TID --> MDD 1.5mgTID ER: 0.375mg qd --> 4.5mg qd DDI: cimetidine
30
ropinorole dosing DDI
0.25mg TID --> 24mg/d 2mg qd --> 24mg/d DDI: R is substrate of 1A2 --| 1A2: cipro, clarithro, erythro, cimetidine, diltiazem, fluvoxamine, norflox, omeprazole, ritonavir
31
bromocriptine moa CI AE DDI
MOA: antag at D1, ag at D2, suppresses prolactin secretion CI: breastfeeding, eclampsia, ergot hypersensitivity, uncontrolled HTN AE: CNS, GI, pulmonary fibrosis DDI: BP meds, erythro
32
cabergoline FDA approved? AE
only FDA approved for prolactinemia AE: heart valve damage
33
apomorphine use dose pearl AE
used in advanced PD for off periods 2mg SQ under medical supervision (can increase by 1mg every few days, rotate sites) AE: NV, dizziness, angina, somnolence, dyskinesia, falls, yawning, rhinorrhea pearl: PRE-tx w antiemetic 3 days before ; trimethobenzamide
34
rotigotine dose caution AE
2mg/24h, inc qwk 2mg/d up to 6mg caution: heat, MRI AE: site reaction, CNS, GI, peripheral edema
35
pt experiencing off or on-off response with medication what can be done
increase frequency before increasing dose change to CR adjunctive DA ag/MAOi/COMT/amantadine
36
pt is experiencing off, no on (always in the bottom of graph) what can be done
delayed stomach emptying/dec absorb- inc dose/freq/water, use ODT, APO SQ, EMPTY STOMACH
37
peak-effect (peak on) dyskinesia what can be done to help
dec dose, use CR Sinemet instead of IR dec freq., add amantadine, DA ag
38
pt experiencing dystonia (painful cramping), what can be done
CR at bedtime, DA ag, baclofen, botox
39
pt experiencing freezing while on PD med, what can be done
inc dose, add DA ag, gait modification, PT
40
pt taking Levodopa but having delayed onset what can be done
empty stomach, water, avoid protein if CR, add IR or switch to IR
41
PD depression tx
pramipexole, venlafaxine
42
PD dementia and cognitive impairment tx
rivastigmine
43
PD insomnia tx
eszopiclone, melatonin
44
PD excessive daytime somnolence tx
modafanil
45
orthostatic hypotensoin in PD tx
fludrocortisone midodrine droxidopa - best
46
sexual dysfunction in PD tx
sildenafil
47
constipation in PD tx
PEG, probiotics and fiber, lubiprostone
48
urinary frequency in PD tx
solifenacin
49
drooling in PD tx
glycopyrrolate, botox
50
pt admitted for psychosis in dementia stepwise approach
1. eval hypoxemia, infection, electrolyte disturbances 2. simplify regimen (anticholinergics dc and switch, taper d/c amantadine, selegiline, taper d/c da ags, consider dec ldopa, dc COMT) 3. consider atypical APs: quetiapine, clozapine-monitor, pimvanserin tartrate)
51
pimvanserin tartrate MOA, use, AE
5HT2A/2C inverse agonist for hallucinations and delusions in PD BBW: inc death in elderly w dementia treated w APs AE: QT p, peripheral edema, nausea, confusion